Analyst stock forecast
Caris Life Sciences, Inc. Stock Forecast and Analyst Price Target
CAI analyst target range, upside, consensus rating and coverage count.
Direct answer
Caris Life Sciences, Inc.'s average price target is $27.00.
The target implies +16% from the recorded current price, and the consensus rating is Buy.
The verified range is $22.00 to $36.00, with 12 analysts in the current consensus when available.
Forecast evidence checked August 11, 2026.
Get free Caris Life Sciences, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $23.29
- Average price target
- $27.00
- High price target
- $36.00
- Low price target
- $22.00
- Target upside
- +16%
- Consensus rating
- Buy
- Analysts
- 12
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026